Pathogens can release extracellular vesicles (EVs) for cell-cell communication and host modulation. EVs from Plasmodium falciparum, the deadliest malaria parasite species, can transfer drug resistance genes between parasites. EVs from late-stage parasite-infected RBC (iRBC-EVs) are immunostimulatory and affect endothelial cell permeability, but little is known about EVs from early stage iRBC. We detected the parasite virulence factor PfEMP1, which is responsible for iRBC adherence and a major contributor to disease severity, in EVs, only up to 12-hr post-RBC invasion. Furthermore, using PfEMP1 transport knockout parasites, we determined that EVs originated from inside the iRBC rather than the iRBC surface. Proteomic analysis detected 101 parasite and 178 human proteins in iRBC-EVs. Primary human monocytes stimulated with iRBC-EVs released low levels of inflammatory cytokines and showed transcriptomic changes.
| INTRODUCTION
The apicomplexan parasite Plasmodium falciparum caused 99% of the estimated 429,000 malaria deaths in 2015, predominantly affecting children in sub-Saharan Africa (WHO Malaria Report 2016). Mortality arises from severe disease complications such as anaemia, metabolic acidosis, and cerebral malaria (White et al., 2014) . P. falciparum invades red blood cells (RBC) and progresses through several distinct stages over a 48-hr asexual life cycle. After invasion, the parasite is surrounded by the parasitophorous vacuole and is visualised as a ring in microscopy, hence named "ring stage." As the parasite develops inside the RBC, it enters the trophozoite stage and then matures into a schizont prior to RBC rupture and parasite egress in the form of many invasive merozoites.
As the parasite progresses through the intraerythrocytic life cycle, the host cell is significantly altered. These changes are caused by the production and export of parasite proteins, of which many are inserted into the RBC plasma membrane, and by the introduction of parasite organelles, such as the Maurer's Clefts, into the RBC cytoplasm (Maier, Cooke, Cowman, & Tilley, 2009) . A key parasite protein at the RBC surface is P. falciparum erythrocyte membrane protein 1 (PfEMP1).
PfEMP1 binds to host cell surface molecules such as ICAM-1, CD36, and CSA and causes iRBC sequestration in blood vessels and organs in order to avoid destruction in the spleen (Baruch, Gormely, Ma, Howard, & Pasloske, 1996; Reeder et al., 1999; Schofield & Grau, 2005) . This adherence is a major contributor to P. falciparum pathogenesis and can lead to particularly severe complications when sequestration occurs in blood vessels of the brain (Jensen et al., 2004; Tembo et al., 2014) . Furthermore, PfEMP1 can dampen cytokine release from NK cells, γδ T cells (D'Ombrain et al., 2007) , and monocytes (Sampaio, Eriksson, & Schofield, 2017) . PfEMP1 is produced early in the intraerythrocytic life cycle, already detectable in the parasite 8-hr postinvasion, and is shuttled through Maurer's Clefts to appear at the iRBC surface from 16-hr postinvasion (Kriek et al., 2003; McMillan et al., 2013) . As a result, cytoadherence of the iRBC occurs when parasites are in the trophozoite stage, but early ring-stage parasites remain in circulation.
There have been increasing investigations into the role of extracellular vesicles (EVs) in malaria biology and pathogenesis (recently reviewed here; Sampaio, Cheng, & Eriksson, 2017) . EVs are bilipid membrane vesicles that are released from cells, either by budding from the plasma membrane or by generation and release of intravesicular bodies. They generally contain proteins and nucleic acids and can fuse or be endocytosed by other cells. Mouse models of Plasmodium infection showed that parasite-derived EVs can induce an immune response (Couper et al., 2010; Martin-Jaular, Nakayasu, Ferrer, Almeida, & Del Portillo, 2011) . Similarly, EVs from late-stage trophozoite/schizonts can induce an inflammatory response from human monocytes/macrophages (Mantel et al., 2013) and can modulate epithelial cell gene expression and barrier properties (Mantel et al., 2016) . Furthermore, P. falciparum iRBC-derived EVs allow cell-cell communication between parasites, and EVs from ring-stage iRBC were particularly efficient at parasite-to-parasite gene transfer (Mantel et al., 2013; Regev-Rudzki et al., 2013) . However, the study of EVs from the early ring-stage of the asexual lifecycle has been limited. Therefore, we aimed to investigate this population of vesicles and examine the effect of EVs on host innate immune cells.
We hypothesised that ring-stage iRBC would release vesicles with unique characteristics, and that these could stimulate host monocytes.
We analysed EVs from iRBC at different life stages and found that the protein content of EVs changed over time. Intriguingly, we discovered that the key P. falciparum virulence factor PfEMP1 was present only in EVs from early ring-stage parasites, many hours before PfEMP1 appearance on the iRBC surface, providing a means of the parasite to disseminate PfEMP1 early in infection. Furthermore, these ring-stage EVs induce low-level cytokine responses from human primary monocytes, while altering the cellular transcriptome. The EV effects on gene expression were partially PfEMP1-dependent, suggesting a role for EVdelivered PfEMP1 in modulating the host immune response to infection.
| RESULTS

| Extracellular vesicles from early stage iRBC contain the virulence factor PfEMP1
To investigate the potential changes in the protein content of EVs released during the parasite life cycle, vesicles were obtained from iRBC (iRBC-EVs) at different stages of maturity. Wild-type CS2 iRBC were tightly synchronised to a 4-hr window, and vesicles were isolated in 12-hr increments, that is, at 12-, 24-, 36-, and 48-hr postinvasion, representing ring, early trophozoite, late-trophozoite, and schizont stages ( Figure 1a ). The iRBC-EVs from the four different stages were analysed by Western blot for the presence of P. falciparum proteins PfEMP1, Plasmepsin V, aldolase, and actin depolymerisation factor (ADF1).
PfEMP1 is a key virulence factor, and EVs derived from ring-stage iRBC contained PfEMP1, whereas PfEMP1 was absent in EVs after 12 hr (Figure 1b) . Notably, PfEMP1 is reported to appear on the iRBC surface from 16-hr postinvasion and peak at 36-hr postinvasion (Kriek et al., 2003) , and we confirmed this timing with iRBC lysates at the indicated 12-hr intervals (Figure 1c ). PfEMP1 is therefore present in iRBC-EVs significantly earlier than its expression on the iRBC surface. The levels of other parasite proteins in iRBC-EVs also varied at different life stages.
Parasite aldolase, an actin-binding protein involved in parasite invasion and motility (Diaz et al., 2014) , was found at high levels in both ring-stage and schizont-stage iRBC-EVs, whereas parasite ADF1, another actinbinding protein (Wong et al., 2014) , was abundant in iRBC-EVs from the schizont stage (Figure 1b) . SR1 is an RBC protein and known marker of erythrocyte-derived vesicles (Salzer, Hinterdorfer, Hunger, Borken, & Prohaska, 2002) and was used to demonstrate equivalent loading of all samples. Thus, we find that parasite proteins in iRBC-EVs vary throughout the parasite life cycle and that PfEMP1 is present only in EVs from early ring-stage iRBC.
| PfEMP1 presence in extracellular vesicles is independent of transport proteins SBP1 and PTP1
The transport of PfEMP1 from the parasite within the parasitophorous vacuole to the iRBC plasma membrane is a regulated process involving many parasite proteins (Maier et al., 2009 ). Genetic ablation of key proteins in this transport pathway, such as skeletal binding protein 1 (SBP1) or PfEMP1 transport protein 1 and 2 (PTP1 and PTP2), results in PfEMP1 being expressed but localised in the parasite or parasitophorous vacuole rather than the iRBC plasma membrane (Cooke et al., 2006; Maier et al., 2007; Maier et al., 2008) . EVs from CS2-SBP1-KO, CS2-PTP1-KO, and CS2-PTP2-KO iRBC were analysed for the presence of PfEMP1. iRBC-EVs from both CS2-SBP1-KO and CS2-PTP1-KO still contained PfEMP1, whereas PfEMP1 expression was negligible in both CS2-PTP2-KO iRBC and iRBC-EVs (Figure 2a) . However, parasite aldolase and ADF1 were still detected in EVs from CS2-PTP2-KO iRBC. Thus, SBP1 and PTP1 are not required for PfEMP1 incorporation into EVs, or FIGURE 2 Analysis of vesicles from PfEMP1 transport knockout and PfEMP1 expression knockout parasite strains. Lysates from uRBC/iRBC and ring-stage vesicles from PfEMP1 transport knockout parasites PTP1-KO, PTP2-KO, and SBP1-KO (a), and lysates and ring-stage vesicles from uRBC, 3D7-WT, and PfEMP1 expression knockout 3D7-UpsC R (b) were analysed for expression of PfEMP1 and other parasite proteins by
Western blot. Arrow indicates PfEMP1, and asterisk indicates cross-reactivity with human spectrin. Representative images of minimum two independent repeats FIGURE 1 Variation in parasite protein content in vesicles from different iRBC life stages. CS2-infected iRBC were tightly synchronised, and cell culture supernatants were collected at 0-12 hr, 12-24 hr, 24-36 hr, and 36-48 hr. (a) Giemsa stain of parasite cultures at supernatant collection time. (b) Lysates from uRBC, trophozoite-stage CS2 iRBC, and CS2 vesicles from culture supernatants collected at the specified time points were analysed by Western blot for indicated proteins. (c) Lysates from uRBC or CS2 iRBC at the specified time points were analysed by Western blot; arrow indicates PfEMP1, and asterisk indicates cross-reactivity with human spectrin. Representative images of two independent repeats EV release from iRBC. These data suggest that the EVs originate from the intracellular parasite rather than budding from the RBC membrane, as vesicles budding from the membrane of CS2-SBP1-KO or CS2-PTP1-KO iRBC would not contain PfEMP1.
| Proteomic analysis of iRBC-EVs allowed quantitative discovery of parasite and human proteins in EVs
In order to investigate the potential downstream effects of PfEMP1 in iRBC-EVs, we first performed an in-depth analysis of the proteins present in EVs from ring-stage wild-type 3D7 (3D7-WT) and the 3D7-UpsC R PfEMP1 knockout parasite strain. The 3D7-UpsC parasite contains the hdhfr gene, which confers resistance to WR99210, downstream of the UpsC PfEMP1 promoter (Voss et al., 2006 Figure 3a ). The density of these fractions was 1.10-1.12 g/ml (Figure 3b ), which corresponds to the expected range for exosomes (Tauro et al., 2012) . Fractions 7 and 8 from 3D7-WT and 3D7-UpsC R were pooled, and three independent biological replicates were processed for mass spectrometry.
Peptides detected by mass spectrometry were searched separately against both human and P. falciparum databases, and low stringency hits were determined. A total of 178 human proteins and 101 parasite proteins were identified (Tables 1 and S1 ). PfEMP1 could not be reliably identified in these data sets, despite being identified by Western blot analysis. When the LFQ intensity measurements of human and Plasmodium proteins were compared to intensities of proteins from the Maxquant contaminant database, Plasmodium proteins were predominately of lower abundance, whereas contaminant proteins (e.g., serum albumin) dominated higher abundance proteins ( Figure S1 ). As a result, vesicle proteins were less likely to be sampled for MS/MS and more likely to be below detection limits, which are the likely explanations for nondetection of PfEMP1. Other parasite proteins of interest that were reliably identified by proteomics include merozoite surface protein 1 (MSP-1), knob-associated histidine-rich protein (KHARP), PfEMP3, and stevor (Table S1 ). Furthermore, the exosome marker flotilin-1 and P. falciparum aldolase, which were detected by Western blot analysis, were reproducibly identified by proteomics.
The gene ontology (GO) annotations for proteins were downloaded from UniProt databases for human and Plasmodium (Table   S2 ). Similarities in overarching molecular function of human and malaria proteins in iRBC-EVs included "Endopeptidase Activity" and "ATP Binding" as the most abundant functions in both datasets (Figure 3c ). In contrast, proteins with functions in "Structural Constituent of Ribosomes," "GTPase Activity," "Histone Binding," and "Structural Constituent of Cytoskeleton" were overrepresented in parasites proteins but not in human. Moreover, "Serine-type Endopeptidase," "Heme/Oxygen/Iron Binding," "Cadherin Binding," and "Receptor Binding" functions were overrepresented in human proteins only. Additionally, the "Extracellular Exosome" GO annotation for cellular compartment was also enriched in the human protein dataset (Table S2 ). Network analysis using the STRING database (Szklarczyk et al., 2017) showed protein interactions and highlighted clusters for "Proteasome-associated Proteins" for both Plasmodium and human data sets (Figure 3d ). "Robosomal Proteins," "Rhoptry/Antigen," and "Membrane/Antigen" protein interaction clusters are present for Plasmodium proteins, whereas "Complement/Protease," "Erythrocyte
Membrane," "Haemoglobin-binding Proteins," and "Flotillin" clusters are present for human proteins, highlighting functional differences in the two data sets.
Quantitative analysis of protein abundance between 3D7-WT and 3D7-UpsC R iRBC-EVs was performed using LFQ intensities for reproducibly identified proteins via a two-sample t test. For proteins with a significant p value (<.05), the difference between means was also assessed, which demonstrated that the majority of statistically significant proteins were not accompanied by large changes in abundance (Table S3 , Figure 3e ). Of the statistically significant, differentially expressed (DE) proteins (Table 2) , one human protein (Histone H2B) and no parasite proteins found to be above the cut-off log-transformed mean difference of 2. Furthermore, several proteins were reproducibility identified exclusively in one treatment group but were not detected in any replicate of the other and could not be means tested. Four Plasmodium and seven human proteins were detected exclusively in 3D7-UpsC R iRBC-EVs, whereas two human proteins only detected in 3D7-WT iRBC-EVs (Table S4 ). These proteins could be of low abundance and below detection limits ( Figure S1 ) or could represent biological differences between groups.
2.4 | Extracellular vesicles from ring-stage iRBC are less immunostimulatory than whole trophozoite iRBC Mantel et al., (2013) reported that CD14+ monocytes were the main immune cell population targeted by iRBC-EVs and that monocytederived macrophages stimulated with EVs from late-stage iRBC upregulated the expression of IL-1β, IL-6, IL-10 and IL-12, and released IL-10 and TNF. However, the response to ring-stage iRBC-EVs was not evaluated. We have recently shown that PfEMP1 located on the iRBC surface can specifically modulate the monocyte immune response to parasites . However, to investigate whether the presence of PfEMP1 in ring-stage iRBC-EVs had a similar effect on monocytes, the optimal EV concentration for cell stimulation was first determined by flow cytometry to achieve the highest response (iRBC-EV) to background (uRBC-EV) signal ( Figure S2 ). The cytokine and chemokine production from primary human monocytes in response to iRBC-EVs from ring-stage 3D7-WT and 3D7-UpsC R was subsequently assessed. Furthermore, the magnitude of the cytokine response was compared to whole trophozoite-stage iRBC, in order to provide a reference for cytokine responses to known immunostimulatory parasites within the same donor. Overall, these data showed that iRBC-EVs from early ring-stage induce low or no cytokine responses from the majority of human donors, but high donor heterogeneity exists. Differential expression of genes in monocytes stimulated with uRBC-EVs, 3D7-WT iRBC-EVs, or 3D7-UpsC R iRBC-EVs was determined, with a 5% false discovery rate (FDR; Figure 5b ,c). There were 181 DE genes in monocytes stimulated with 3D7-WT iRBC-EV compared to uRBC-EVs, whereas there were 530 DE genes when cells were stimulated with 3D7-UpsC R iRBC-EVs (Figure 5b and Tables 3 and S5 ).
There was no statistically significant difference in gene expression when cells were stimulated with vesicles from 3D7-WT compared to 3D7- Mean's difference: measure of difference in abundance between means as log-fold change, positive indicating increase, negative indicating decrease; cut-off for biologically meaningful difference set at Log-fold 2.
changed in 3D7-WT iRBC-EV-stimulated cells. However, nearly half of the top 20 most DE genes in both treatments were the same (Table 4 ).
The majority of these common DE genes are involved in transcription/ translation, and all were upregulated in both sample sets. As there were minimal changes in protein content of iRBC-EVs from 3D7-WT versus 3D7-UpsC R , with the exception of PfEMP1, it is possible that differences in monocyte transcriptional changes between the two stimulations were due to PfEMP1 presence/absence.
| Pathway analysis of gene expression changes in monocytes treated with iRBC-derived extracellular vesicles
In order to characterise the functional differences in the effect of monocyte stimulus with 3D7-WT and 3D7-UpsC R iRBC-EVs, the GO pathways enriched in each data set were inferred (Tables 5 and S6 ).
Of the 20 most highly associated GO terms in the iRBC-EV stimulated samples, 10 were common between the two treatments. In addition to transcription/translation processes, there was an enrichment of GO terms related to cellular metabolism/catabolism. Of interest are the enriched GO terms that were not in common between the two treatments. These included "defence response," "cellular response to cytokine stimulus," and "response to stress" enriched only with 3D7-UpsC R iRBC-EV stimulus, and not with 3D7-WT iRBC-EVs. In addition, there was enrichment of terms involving antigen presentation in both treatment groups.
Type I interferons were recently found to be released in response to human malaria infection, but to suppress immunity to the infection (Mantel & Marti, 2014; Sampaio, Cheng, & Eriksson, 2017) .
Many parasite species produce EVs and employ these for modulation of host cells, which enhances pathogenesis (Szempruch et al., 2016; Twu et al., 2013) and/or inhibits immune responses (Buck et al., 2014; Silverman et al., 2010 PfEMP1 is a transmembrane protein that is a key virulence factor in P. falciparum malaria, largely responsible for the enhanced pathogenesis and mortality associated with this disease (Miller, Baruch, Marsh, & Doumbo, 2002) . We demonstrated that PfEMP1 is present in a novel parasite compartment and may affect the host response to infection.
The protein content of P. falciparum iRBC-EVs differed throughout the parasite life cycle, notably with the presence of PfEMP1 in EVs released only from early ring-stage iRBC. Of note, the limited timeframe in which PfEMP1 was observed in EVs was different from the appearance of PfEMP1 at the iRBC plasma membrane. PfEMP1 trafficking occurs through intracellular vesicles moving from the parasite to the cell membrane, via the Maurer's clefts, (McMillan et al., 2013) . It is conceivable that the PfEMP1-containing EVs studied here were released as a byproduct of PfEMP1 transport to the RBC surface.
However, PfEMP1 is only present in EVs in the first 12-hr postinvasion, whereas the intracellular transport of PfEMP1 still occurs after 12 hr, indicating that the processes are temporally distinct. Therefore, it is unlikely that the intracellular PfEMP1-trafficking vesicles correspond to the EVs studied here. This suggests that the inclusion of PfEMP1 in EVs could be a specific mechanism applied by the parasite to affect host cells.
EVs from late-stage iRBC contain miRNA that can downregulate target genes in endothelial cells to affect barrier function (Mantel et al., 2016) . Because PfEMP1 can interact with a variety of host cell antibodies to protect the parasite against targeted immune attack. It would be interesting to evaluate whether parasite EVs from malariainfected patients bind parasite-specific antibodies in vivo.
Although we did not directly investigate the origin of iRBC-EVs, these vesicles were enriched for the exosome marker flotilin-1, and proteins detected in iRBC-EVs by proteomics were highly associated with the exosomal cell compartment according to GO analysis. This suggests that these iRBC-EVs could be exosomes or at least originate from within the parasite, rather than being microvesicles shed from the iRBC plasma membrane. This is further supported by use of PfEMP1 transport knockout parasites, which express PfEMP1 but lack PfEMP1 on the iRBC surface Maier et al., 2008) .
PfEMP1 was present in iRBC-EVs from these knockout parasites indicating that iRBC-EVs originated from the intracellular parasite and were released through a still unknown mechanism. Moreover, another study of P. falciparum-derived microparticle/microvesicles, which are large vesicles derived from the iRBC plasma membrane,
showed that these contain the parasite ring-infected erythrocyte surface antigen, which we did not detect in our iRBC-EVs (Nantakomol et al., 2011) , further distinguishing them from the more widely investi- Human primary monocytes were chosen as the target cell population for investigation of early stage iRBC EV effects, because these were the primary responders to EVs from late-stage iRBC (Mantel et al., 2013) .
Although ring-stage iRBC-EVs were less stimulatory than intact tropho- investigated, but given that many parasite proteins are GPI-anchored (e.g., MSP-1), it is plausible that GPI is present in iRBC-EVs. Moreover, there were high peptide counts from heat shock proteins (Hsp) in our proteomic analysis of ring-stage iRBC-EVs. Hsp are important in parasite survival and adaptation to hostile environments and are exported to the iRBC cytoplasm during infection (Shonhai, Boshoff, & Blatch, 2007) .
Indeed, Hsp70 is a danger signal known to be enriched in EVs from other species (De Maio, 2011) , and Hsp70 in EVs can activate innate immune cells (Gastpar et al., 2005; Lv et al., 2012; Vega et al., 2008) . The heat shock proteins in iRBC-EVs could be detected as danger signals and thus induce monocyte activation. Conversely, EVs used in this work did not contain hemozoin, as this was removed during the EV isolation process.
The lack of pro-inflammatory hemozoin, and the overall lower quantities of parasite agonists, supports the observed low capacity of ring-stage iRBC-EVs to stimulate innate immunity. Thus, these EVs may predominantly provide the parasite with a means of cell-cell communication that has minimal interference from host immune cells. It is important to note, however, that some donors were able to respond to iRBC-EVs, indicating that natural variations in human innate responses likely play a role in detection of ring-stage iRBC-EVs.
By using transcriptomics to study monocyte gene expression changes in response to ring-stage iRBC-EVs, we further dissected the effect of these vesicles on human monocytes and the contribution of PfEMP1-positive iRBC-EVs and upregulated pathways involving "defence response," "cellular response to cytokine stimulus," and "response to stress," which were not upregulated with the PfEMP1-positive iRBC-EVs. PfEMP1, when in the biologically relevant concentrations and cellular localisation of the iRBC surface, inhibits monocyte responses . It is possible that PfEMP1 could also exert an immune modulatory effect on monocytes when delivered via EVs. Hence, PfEMP1 might not affect EV uptake by monocytes but could potentially manipulate monocyte responses to stimulus, as is seen with PfEMP1 on the iRBC surface. However, further work is still required to unequivocally demonstrate this effect.
Recent reports have shown that EVs from late-stage iRBC contain RNA. Because ring-stage iRBC-EVs can provide a means of exchange of genetic material, then these vesicles must also contain nucleic acids.
Therefore, nucleic acids in ring-stage iRBC-EVs could also account for transcriptional changes in monocytes. Although we did not detect parasite RNA in monocytes treated with iRBC-EVs, it is possible that parasite nucleic acids were delivered to host cells but degraded prior to RNA extraction. Studies into the nucleic acid content of ring-stage iRBC-EVs, and their effects on host cells, are needed in order for the function of these vesicles to be completely understood.
The work presented here demonstrates that EVs from early stage P. falciparum-infected RBC affect host monocytes, modifying gene expression while inducing low cytokine secretion. As there have been numerous examples that pathogen-derived EVs can modulate host cells in order to inhibit the immune response and promote pathogen survival, P. falciparum might employ EVs for similar outcomes. These findings could have important implications for our understanding of parasite modulation of host immunity and warrant further investigation into the breadth and magnitude of their effects.
| EXPERIMENTAL PROCEDURES
| Parasite culturing
Reagents were purchased from Sigma-Aldrich unless otherwise specified. Parasites were maintained in RPMI-1640 medium pH 7.4, 25-mg/ml HEPES, 50-μg/ml hypoxanthine, 2-mg/ml sodium bicarbonate, and 20-μg/ml gentamycin and supplemented with 5% human serum and 0.25% AlbumaxII. Parasites were grown in pooled donor RBC provided by the Australian Red Cross at 4% haematocrit and incubated at 37°C in 1% O 2 , 4% CO 2 , and 95% N 2 . Wild-type parasite strains used were 3D7 and CS2. PfEMP1 knockdown 3D7-UpsC R (Voss et al., 2006) and CS2 parasites with the disrupted SBP-1 (PF3D7_0501300), PTP-1 (PF3D7_0202200, PFB0106), and PTP-2 (PF3D7_0731100, MAL7P1.172) genes, referred to, respectively, as CS2-SBP1-KO, CS2-PTP1-KO, and CS2-PTP2-KO, were kindly provided by Alan Cowman Maier et al., 2008) .
3D7-UpsC R parasites cultured in the presence of 4-mg/ml blasticidin-S and 4-nM WR99210 do not express PfEMP1 (Voss et al., 2006) .
Cultures were routinely screened for mycoplasma contamination using MycoAlert Plus Kit (Lonza).
Knob-expressing parasites were selected for by gelatin flotation fortnightly (Goodyer, Johnson, Eisenthal, & Hayes, 1994) . Parasite cultures were synchronised by treating ring-stage parasites with 5% sorbitol solution at 37°C for 10 min to lyse trophozoite/schizont-stage parasites. For tight synchronisation, parasites were grown until schizont stage, magnet purified by cell sorting on CS columns (Miltenyi Biotec), and added to fresh uRBC in culture medium for up to 4 hr to allow invasion, then remaining trophozoites/schizonts were lysed using 5% sorbitol (McMillan et al., 2013) . For cell stimulations, magnetic cell-sorted iRBC was used.
| Isolation of iRBC vesicles
Parasites or uRBC were grown in 0.5% AlbumaxII for 12 hr, unless otherwise indicated, and culture medium was collected for vesicle isolation. Vesicles were isolated as described previously (Lässer, Eldh, & Lötvall, 2012) . Briefly, cells and cellular debris (e.g., hemozoin) were removed by sequential centrifugation at 300 × g for 5 min and 3,000 × g for 10 min. Large vesicles, cellular organelles, and debris were further removed by passing supernatant through 0.2-μm filter (Sartsted). Vesicles were pelleted by ultracentrifugation in H 2 O 2 -treated Optiseal tubes (Beckman Coulter) at 120,000 × g overnight at 4°C in a Ti70 rotor, resuspended in 25 ml of PBS, and ultracentrifuged at 120,000 × g for 4 hr at 4°C. Vesicle pellets were resuspended in 50-100 μl of PBS and maintained on ice or stored at −80°C. A flow chart of vesicle preparation and usage is show in Figure   S3 . For cell stimulation assays, freshly isolated vesicles were used.
Protein concentrations were determined using BCA assay (Pierce) according to manufacturer's instructions.
| SDS-PAGE and Western blotting
Samples were solubilised with NuPAGE LDS sample buffer, reduced with 2-mecraptoethanol, analysed on 3-8% Tris-Acetate gels (for 
| Proteomics
Culture medium from early ring-stage parasites cultured for 12 hr (40 ml, 4% haematocrit, 8% parasiteamia) was centrifuged at 3,000 × g for 10 min and filtered through a 0.2-μm syringe filter.
Samples were concentrated to 1 ml by centrifugal filtration using Vivaspin 20 Polyethersulfone 100,000 MWCO tubes (Sartorius) and fractionated by density using discontinuous Optiprep gradients (Van Deun et al., 2014) . Columns were centrifuged in SW40Ti rotor at 100,000 × g for 18 hr at 4°C. Twelve 1-ml fractions were collected, and density of fractions was measured using a refractometer (Metler Toedo). Fractions were diluted in PBS and centrifuged in 70 Ti rotor at 120,000 × g for 4 hr. Pellets were resuspended using NuPAGE LDS sample buffer and stored at −20°C.
EV protein was solubilised in 2.5% SDS in 100-mM Tris (pH 8),
reduced with 10-mM DTT followed by alkylation with 15-mM IAM.
Proteins were precipitated by methanol-chloroform (Wessel & Flügge, 1984) , resolubilised in 8-M Urea in 100-mM Tris (pH 8), and protein concentration equalised across samples (BCA assay; Pierce). Protein was digested overnight with Trypsin (Promega) at 37°C (1-μg enzyme to 100-μg protein). Samples were acidified with 1% trifluoracetic acid, desalted using solid phase extraction with tips packed with styrene divinyl benzene (3M Empore), and fractionated into three fractions as described (Rappsilber, Mann, & Ishihama, 2007) . Extracts were dried by vacuum centrifugation and reconstituted in 2% acetonitrile, 0.1% trifluoroacetic acid for nanoflow liquid chromatography tandem mass spectrometry (Nano-LC-MS/MS).
Samples were analysed by LC-MS/MS using Orbitrap Lumos mass spectrometer (Thermo Scientific) fitted with nanoflow reversed-phase HPLC (Ultimate 3000 RSLC, Dionex). The nano-LC system had an Acclaim Pepmap nanotrap column and Pepmap RSLC analytical column (Dionex-C18, 100 Å, 75 μm × 2 cm and 75 μm × 50 cm, respectively).
One microlitre of the peptide mix was loaded at an isocratic flow of Database searching was performed using MaxQuant (version 1.5.5.1) for LFQ (Cox & Mann, 2008; , using the PlasmoDB 3D7 protein coding sequence file (Aurrecoechea et al., 2009 ) for parasite proteins, and human proteins were searched against reviewed protein entries from UniProt. Default parameters were used for target and decoy searching with an FDR of 1% imposed for peptide-to-spectrum matches, and the LFQ minimum ratio count set to 1 and matching between runs set to "match from and to."
Oxidation of methionine and N-acetylation of proteins' N-termini were set to variable modifications, and carbidomethylation of cysteine was considered fixed modification. The Maxquant output file was imported in Perseus version 1.5.5.3) , and proteins/protein groups identified in the reverse database, contaminant database, or only by site were removed. Low stringency proteins were filtered to detection in a minimum of three replicates across the six replicates of both treatment groups. For statistical analyses, high stringency proteins were filtered to only include those reproducibly identified in all three biological replicates within at least one sample group.
Gene ontology functions were obtained from Uniprot for nonhomologous proteins from human and Plasmodium, and GO annotations for molecular function were used for further analysis. 
| Flow cytometric optimisation of EV concentration for cell stimulation
Cryopreserved human PBMCs from naïve Melbourne donors were stimulated with 1, 5, or 10 μg/ml EVs for 12 hr at 37°C in 5% CO 2 .
Brefeldin A (10 μg/ml; Sigma, St Louis, MO) and GolgiStop (2 μM; BD Biosciences, San Jose, CA) were added for the final 8 hr of Monocytes were enriched using isosmotic Percoll (GE Healthcare) density barrier centrifugation as described (de Almeida, Silva, Barral, & Barral Netto, 2000) . Briefly, isosmotic Percoll solution (nine parts Percoll to one part NaCl 1.5 M) was mixed 1:1 (v/v) with PBS/citrate (NaH 2 PO 4 1.49 mM, Na 2 HPO 4 9.15 mM, NaCl 139.97 mM, C 6 H 5 Na 3 O 7 .2H 2 O 13 mM, pH 7.2). Freshly isolated PBMC (5 ml at 1-2 × 10 7 cells/ml in PBS) was overlaid on 9-ml isosmotic Percoll/PBS/citrate solution in 15-ml centrifuge tubes and centrifuged at 400 × g for 35 min. Monocytes at the PBS-Percoll interphase were collected and washed twice with PBS before culturing in medium (RPMI-1640, 2-mM L-glutamine, 25-μM HEPES, 100-U/ml penicillin, and 100-μg/ml streptomycin) supplemented with 10% FCS. Monocyte purity was verified by CD14 surface staining (CD14-FITC, clone M5E2; BD) and analysed on a FACS Calibur. Purity was on average~80%
(range 75-95%). For RNA-seq experiments, monocytes were further purified by FACS sorting gating on monocytes based on forward and side scatter. After sorting, monocyte purity was ≥99%.
| Monocyte stimulation with parasite-derived vesicles
Tightly synchronised parasites at a minimum of 5% parasitemia, or uRBC control, were incubated at 4% haematocrit in 0.5% Albumax parasite medium for 12 hr prior to supernatant collection and vesicle purification. For uRBC control, fresh uRBC were washed in RPMI-HEPES and incubated at 37°C for 48 hr prior to setting up for vesicle collection. Vesicle preparations were maintained endotoxin-free to exclude potential non-specific responses. Monocytes from naïve Melbourne donors were added to triplicate wells in 96-well U-bottom plates at 2 × 10 5 cells/well and stimulated with vesicles (5 μg/ml), or LPS positive control (3.5 ng/ml), for 12 hr at 37°C in 5% CO 2 . In some instances, monocytes were also stimulated with 6 × 10 5 cells/well uRBC or iRBC. After incubation, plates were centrifuged and cell-free supernatants were collected and stored at −80°C until ready for use.
| Multiplex cytokine/chemokine ELISA
Cell culture supernatants from stimulated monocytes (triplicate wells)
were pooled and tested in duplicate. Multiplex ELISA (Bio-Plex Pro Assay; Bio-Rad) on a Luminex platform was performed according to manufacturer's instructions.
| Library preparation and transcriptome sequencing
Human primary monocytes from six donors were isolated and stimulated with vesicles as described above for 6 hr. RNA was extracted 
| Gene expression analysis
All samples were aligned to the human genome (GRCh38) using the Rsubread aligner (Liao, Smyth, & Shi, 2013) , where greater than 90%
of reads mapped in all samples. The number of fragments overlapping each Entrez gene was summarised using featureCounts (Liao, Smyth, & Shi, 2014) and NCBI RefSeq annotation (ftp://ftp.ncbi.nlm.nih.gov/ gene/DATA/GENE_INFO/). Differential expression analyses were undertaken using the edgeR (McCarthy, Chen, & Smyth, 2012) and limma software packages. Any gene that did not achieve a count per million (CPM) mapped reads of two in at least six samples was deemed to be unexpressed and subsequently filtered from the analysis. Additionally, all genes without current annotation were also removed. Compositional differences between libraries were normalised using the trimmed mean of log expression ratios method (Robinson & Oshlack, 2010) . Counts were transformed to log 2 -CPM with associated precision weights using voom (Law, Chen, Shi, & Smyth, 2014) . Sample-specific quality weights were also calculated using limma's arrayWeights function (Liu et al., 2015) . Differential expression was assessed using linear models and robust empirical Bayes moderated t statistics (Phipson, Lee, Majewski, Alexander, & Smyth, 2016) . p Values were adjusted to control the FDR below 5% using the Benjamini and Hochberg method. To increase precision, the linear models incorporate four surrogate variables. These variables adjust the data for two know batch effects-donor and day of sample preparation ( Figure S4 ). They were computed using limma's wsva function with weight.by.sd set to true.
Gene ontology pathway analyses used the limma goana function.
To make the heat map and multidimensional scaling plot, the expression of each gene was summarised as a log 2 -CPM with a prior count of 2. These values were then adjusted using limma's removeBatchEffect function to incorporate the surrogate variable correction. The plots were made with limma's coolmap and plotMDS functions, respectively. To reduce redundancy in GO terms, the REVIGO program (Supek, Bošnjak, Škunca, & Šmuc, 2011) was applied.
To identify any P. falciparum RNA in the samples, an index was built using the Rsubread package (Liao et al., 2013 ) that contained both the human and falciparum genomes (assemblies GRCh38 and P. falciparum 3D7, respectively). All samples were then aligned to the combined genome using the Rsubread aligner. The number of reads aligning to P. falciparum chromosomes was quantified using featureCounts from Rsubread.
